Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Primary Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Docetaxel|DRUG: Cyclophosphamide|DRUG: Epirubicin|DRUG: 5-fluorouracil
Sponsor: Fudan University